Skip to main content
. 2019 Apr 3;12:2505–2512. doi: 10.2147/OTT.S141040

Figure 2.

Figure 2

Mechanism of action of durvalumab: normal immune response (A); tumor immune invasion (B); and immune response restoration (C).

Abbreviations: MHC, major histocompatibility complex; APC, antigen presenting cell; TCR, T cell receptor; PD1, programmed death receptor; CTLA4, cytotoxic T-lymphocyte-associated protein 4.